FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 750 mg/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2 g/500 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 15 mg/3 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-060 | 71506-060-58 | Epinephrine | 8 mg/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-023 | 71506-023-03 | Glycopyrrolate | .6 mg/3 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-035 | 71506-035-56 | Acyclovir Sodium | 200 mg/100 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 1000 mg/100 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-036 | 71506-036-01 | Atropine Sulfate | .4 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 20 mg/4 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 100 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 4 mg/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 32 mg/250 mL | 2025-2 | valid | 2026-08-10 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-028 | 71506-028-59 | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | .5 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-125 | 63037-125-25 | Glycopyrrolate | 1 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2500 ug/250 mL | 2025-2 | valid | 2026-08-10 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-100 | 63037-100-05 | Fentanyl Citrate | 1000 ug/100 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5526 | 26436-5526-0 | Phenylephrine Hydrochloride, (+/-)-; Tropicamide; Cyclopentolate | 25 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5027 | 26436-5027-2 | Alpha Lipoic Acid | 25 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 20 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5248 | 26436-5248-1 | Progesterone | 125 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-1124 | 26436-1124-1 | Progesterone | 200 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5152 | 26436-5152-1 | Progesterone | 150 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5644 | 26436-5644-1 | Progesterone | 100 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5002 | 26436-5002-1 | Pyridoxine Hydrochloride | 100 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5084 | 26436-5084-3 | Biotin | 10 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5424 | 26436-5424-2 | Sermorelin Acetate | 300 ug | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5591 | 26436-5591-1 | Sildenafil Citrate | 110 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-0001 | 26436-0001-1 | Sildenafil Citrate | 100 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-0059 | 26436-0059-2 | Tadalafil | 20 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5613 | 26436-5613-1 | Tadalafil | 12 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5024 | 26436-5024-3 | Taurine | 50 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-6023 | 26436-6023-3 | Testosterone | 200 mg/1 g | 2025-2 | valid | 2026-08-10 |